Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brand names. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Fortive Corporation

RBC Capital analyst Deane Dray maintained a Hold rating on Fortive on January 14 and set a price target of $56.00. The company’s shares closed yest...

Fortive (FTV) Receives a Hold from RBC Capital

An update from Foresight Vct ( ($GB:FTV) ) is now available. Foresight VCT plc has corrected an earlier announcement to confirm that its new share ...

Foresight VCT Corrects Prospectus Date as It Launches £40m Share Offer

Foresight Vct ( ($GB:FTV) ) has provided an announcement. Foresight VCT plc has launched a new share offer to raise up to £40 million, giving exist...

Foresight VCT Launches £40m Share Offer Ahead of Tax Year-End

In a report released today, Julian Mitchell from Barclays maintained a Hold rating on Fortive, with a price target of $56.00. Mitchell covers the I...

Current Quarter	$0.83	Next Quarter	$0.61
Current Year	$2.64	Next Year	$2.84
QoQ Growth	-26.5%	YoY Growth	+7.6%
3Y EPS CAGR	+13.4%	Target Price	$57.00
Consensus	Buy	Upside	+6.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FTV	$53.70	+1.69%	3.17M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FTV	$53.70	+1.7%	3.17M
3
4
5
6

FTV

FTV

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Fortive Corporation Data in Excel

Get Fortive Corporation Data in Excel